Fu YX - Search Results

1

Type I Interferon Response in Radiation-Induced Anti-Tumor Immunity.

Zhang F, Manna S, Pop LM, Chen ZJ, Fu YX, Hannan R. Zhang F, et al. Among authors: fu yx. Semin Radiat Oncol. 2020 Apr;30(2):129-138. doi: 10.1016/j.semradonc.2019.12.009. Semin Radiat Oncol. 2020. PMID: 32381292 Review.

2

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

Burnette BC, Liang H, Lee Y, Chlewicki L, Khodarev NN, Weichselbaum RR, Fu YX, Auh SL. Burnette BC, et al. Among authors: fu yx. Cancer Res. 2011 Apr 1;71(7):2488-96. doi: 10.1158/0008-5472.CAN-10-2820. Epub 2011 Feb 7. Cancer Res. 2011. PMID: 21300764 Free PMC article.

3

Type I interferon response and innate immune sensing of cancer.

Fuertes MB, Woo SR, Burnett B, Fu YX, Gajewski TF. Fuertes MB, et al. Among authors: fu yx. Trends Immunol. 2013 Feb;34(2):67-73. doi: 10.1016/j.it.2012.10.004. Epub 2012 Oct 31. Trends Immunol. 2013. PMID: 23122052 Free PMC article. Review.

4

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, Li XD, Mauceri H, Beckett M, Darga T, Huang X, Gajewski TF, Chen ZJ, Fu YX, Weichselbaum RR. Deng L, et al. Among authors: fu yx. Immunity. 2014 Nov 20;41(5):843-52. doi: 10.1016/j.immuni.2014.10.019. Epub 2014 Nov 6. Immunity. 2014. PMID: 25517616 Free PMC article.

5

Addition of anti-neu antibody to local irradiation can improve tumor-bearing BALB/c mouse survival through immune-mediated mechanisms.

Ma SY, Song H, Park JH, Choi JH, Kim JH, Kim KH, Park S, Park DH, Kang MS, Kwak M, Fu YX, Choi I, Cho H, Park S. Ma SY, et al. Among authors: fu yx. Radiat Res. 2015 Mar;183(3):271-8. doi: 10.1667/RR13800.1. Epub 2015 Feb 23. Radiat Res. 2015. PMID: 25706775

6

The Role of Adaptive Immunity in the Efficacy of Targeted Cancer Therapies.

Xu MM, Pu Y, Zhang Y, Fu YX. Xu MM, et al. Among authors: fu yx. Trends Immunol. 2016 Feb;37(2):141-153. doi: 10.1016/j.it.2015.12.007. Epub 2016 Jan 7. Trends Immunol. 2016. PMID: 26778079 Free PMC article. Review.

7

Adapting conventional cancer treatment for immunotherapy.

Qiao J, Liu Z, Fu YX. Qiao J, et al. Among authors: fu yx. J Mol Med (Berl). 2016 May;94(5):489-95. doi: 10.1007/s00109-016-1393-4. Epub 2016 Feb 24. J Mol Med (Berl). 2016. PMID: 26910191 Review.

8

Is CD47 an innate immune checkpoint for tumor evasion?

Liu X, Kwon H, Li Z, Fu YX. Liu X, et al. Among authors: fu yx. J Hematol Oncol. 2017 Jan 11;10(1):12. doi: 10.1186/s13045-016-0381-z. J Hematol Oncol. 2017. PMID: 28077173 Free PMC article. Review.

9

DNA sensing and immune responses in cancer therapy.

Qiao J, Tang H, Fu YX. Qiao J, et al. Among authors: fu yx. Curr Opin Immunol. 2017 Apr;45:16-20. doi: 10.1016/j.coi.2016.12.005. Epub 2017 Jan 12. Curr Opin Immunol. 2017. PMID: 28088707 Review.

10

Radiotherapy and immunotherapy: a beneficial liaison?

Weichselbaum RR, Liang H, Deng L, Fu YX. Weichselbaum RR, et al. Among authors: fu yx. Nat Rev Clin Oncol. 2017 Jun;14(6):365-379. doi: 10.1038/nrclinonc.2016.211. Epub 2017 Jan 17. Nat Rev Clin Oncol. 2017. PMID: 28094262 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters